Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Diabetes Topic Center

Featured Article

Headshots
Videos
How Digital Therapeutics Are Changing Disease Management, Diabetes Care
09/13/2023

Featuring Daniel Sontupe, Todd Prewitt, MD, and Yash Prajapati

Featuring Daniel Sontupe, Todd Prewit...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
Switching to Biosimilars Yields Significant Cost Savings For Patients Taking Insulin
04/13/2023
Maria Asimopoulos
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
News
HHS Report Suggests Significant Member Cost Savings With $35 Insulin Cap
01/26/2023
Maria Asimopoulos
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been...
01/26/2023
First Report Managed Care
Headshot of Ann Latner, JD
Commentary
Kansas Attorney General Files Insulin Lawsuit Against Manufacturers, PBMs
01/17/2023
Ann W Latner, JD
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a...
01/17/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
01/13/2023

Angela Hart and Samantha Young, Kaiser Health News

Angela Hart and Samantha Young, Kaise...
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3...
01/13/2023
First Report Managed Care
News
California Seeks to Launch Generic Drug Label to Reduce Insulin Costs
06/08/2022

Angela Hart, Kaiser Health News

Angela Hart, Kaiser Health News ...
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked...
06/08/2022
First Report Managed Care
News
$35 Insulin Cap Under Build Back Better Plan Faces Challenges
03/04/2022

Michael McAuliff, Kaiser Health News

Michael McAuliff, Kaiser Health News ...
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan...
03/04/2022
First Report Managed Care
News
Diabetes Drugs Cost Less Under Medicaid vs Marketplace Plans in Colorado
01/17/2022
Maria Asimopoulos
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care
News
Treatment Lowers Diabetes Rate in Patients With Kidney Disease, Heart Failure
12/22/2021
Jolynn Tumolo
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that...
12/22/2021
First Report Managed Care
News
Effectiveness of Various Type 2 Diabetes Agents Differs With Cardiorenal Outcome
12/20/2021
Jolynn Tumolo
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
Glucokinase Activators Outperform Placebo in Patients With Type 2 Diabetes
11/24/2021
Jolynn Tumolo
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care

Newsfeed

News
HHS Report Suggests Significant Member Cost Savings With $35 Insulin Cap
01/26/2023
Maria Asimopoulos
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been...
01/26/2023
First Report Managed Care
News
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
01/13/2023

Angela Hart and Samantha Young, Kaiser Health News

Angela Hart and Samantha Young, Kaise...
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3...
01/13/2023
First Report Managed Care
News
California Seeks to Launch Generic Drug Label to Reduce Insulin Costs
06/08/2022

Angela Hart, Kaiser Health News

Angela Hart, Kaiser Health News ...
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked...
06/08/2022
First Report Managed Care
News
$35 Insulin Cap Under Build Back Better Plan Faces Challenges
03/04/2022

Michael McAuliff, Kaiser Health News

Michael McAuliff, Kaiser Health News ...
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan...
03/04/2022
First Report Managed Care
News
Diabetes Drugs Cost Less Under Medicaid vs Marketplace Plans in Colorado
01/17/2022
Maria Asimopoulos
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care
News
Treatment Lowers Diabetes Rate in Patients With Kidney Disease, Heart Failure
12/22/2021
Jolynn Tumolo
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that...
12/22/2021
First Report Managed Care
News
Effectiveness of Various Type 2 Diabetes Agents Differs With Cardiorenal Outcome
12/20/2021
Jolynn Tumolo
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
Glucokinase Activators Outperform Placebo in Patients With Type 2 Diabetes
11/24/2021
Jolynn Tumolo
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care
News
A Third of COVID-19 Deaths Linked With Diabetes, Hypertension, Obesity, or Smoking
11/15/2021
Jolynn Tumolo
“These findings support that people with diabetes, hypertension, [and] obesity should be prioritized for vaccination in order to limit the higher death rates in hospital,” researchers wrote.
“These findings support that people with diabetes, hypertension, [and] obesity should be prioritized for vaccination in order to limit the higher death rates in hospital,” researchers wrote.
“These findings support that...
11/15/2021
First Report Managed Care
News
Medicare Patients From Racial/Ethnic Minority Groups Have Inadequate Access to MDPP
11/09/2021
Jolynn Tumolo
“The disproportionate burden of obesity and type 2 diabetes on racial and ethnic minority communities signals an urgent need to accelerate the implementation and coordination of the MDPP,” researchers wrote. 
“The disproportionate burden of obesity and type 2 diabetes on racial and ethnic minority communities signals an urgent need to accelerate the implementation and coordination of the MDPP,” researchers wrote. 
“The disproportionate burden of...
11/09/2021
First Report Managed Care
News
AHA Voices Concern Over CMS Payment Updates to LTC Hospitals
08/07/2024
The American Hospital Association (AHA) expressed deep concern in response to long-term care (LTC) hospital payment updates finalized by the Centers for Medicare & Medicaid (CMS) on August 1, 2024.
The American Hospital Association (AHA) expressed deep concern in response to long-term care (LTC) hospital payment updates finalized by the Centers for Medicare & Medicaid (CMS) on August 1, 2024.
The American Hospital...
08/07/2024
First Report Managed Care
News
Obesity Linked to Distinct Heart Muscle Abnormalities in Patients With HFpEF, Study Finds
08/05/2024
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in...
08/05/2024
First Report Managed Care
News
New Treatment Options Benefit Patients With Relapsed/Refractory Follicular Lymphoma
08/05/2024
Patients with relapsed/refractory follicular lymphoma tend to have a poorer response and shortened progression-free survival with each subsequent treatment, but new treatment options are emerging.
Patients with relapsed/refractory follicular lymphoma tend to have a poorer response and shortened progression-free survival with each subsequent treatment, but new treatment options are emerging.
Patients with...
08/05/2024
First Report Managed Care
News
Sun Exposure Linked With Lower Risk of Follicular Lymphoma
07/30/2024
High sun exposure in warmer months may protect against the development of follicular lymphoma, according to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention.
High sun exposure in warmer months may protect against the development of follicular lymphoma, according to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention.
High sun exposure in warmer...
07/30/2024
First Report Managed Care
News
Updated CDC Recommendation for RSV Vaccination in Older Adults
07/29/2024
The Center for Disease Control and Prevention (CDC) vaccine advisory group updated its recommendation for the use of the respiratory syncytial virus (RSV) vaccine in older adults so that people ages 60 to 74 with certain underlying conditions...
The Center for Disease Control and Prevention (CDC) vaccine advisory group updated its recommendation for the use of the respiratory syncytial virus (RSV) vaccine in older adults so that people ages 60 to 74 with certain underlying conditions...
The Center for Disease Control...
07/29/2024
First Report Managed Care
News
Meta-Analysis Shows Bidirectional Link Between Psoriasis and Asthma
07/26/2024
A recent systematic review and meta-analysis spanning 12.4 million patients found a significant bidirectional association between psoriasis and asthma. Researchers published their findings online in BMC Pulmonary Medicine.
A recent systematic review and meta-analysis spanning 12.4 million patients found a significant bidirectional association between psoriasis and asthma. Researchers published their findings online in BMC Pulmonary Medicine.
A recent systematic review and...
07/26/2024
First Report Managed Care
News
HIV Cases Rise Among Gay Latinos
07/24/2024
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
FTC to Sue Top PBMs Over Drug Price Negotiation Tactics
07/22/2024
FTC to sue the largest pharmacy-benefit managers (PBMs) over drug price negotiation tactics for insulin to make health care more affordable.
FTC to sue the largest pharmacy-benefit managers (PBMs) over drug price negotiation tactics for insulin to make health care more affordable.
FTC to sue the largest...
07/22/2024
First Report Managed Care
News
Increased Testing May Have Played a Role in RSV Surge After COVID-19 Restrictions
07/19/2024
The jump in respiratory syncytial virus (RSV) cases after COVID-19-era social distancing and masking eased was partly due to increased testing in outpatient settings as well as changes to the RSV genome, according to a study published online...
The jump in respiratory syncytial virus (RSV) cases after COVID-19-era social distancing and masking eased was partly due to increased testing in outpatient settings as well as changes to the RSV genome, according to a study published online...
The jump in respiratory...
07/19/2024
First Report Managed Care
News
SDOH Disparities Among Black and Hispanic Patients With Ovarian Cancer
07/18/2024
Research published in Gynecologic Oncology reveals how social determinants of health (SDOH) impact the well-being of Black and Hispanic patients who survived ovarian cancer compared to White survivors, emphasizing the need for targeted...
Research published in Gynecologic Oncology reveals how social determinants of health (SDOH) impact the well-being of Black and Hispanic patients who survived ovarian cancer compared to White survivors, emphasizing the need for targeted...
Research published in...
07/18/2024
First Report Managed Care

Advertisement

Insights

Headshots
Videos
How Digital Therapeutics Are Changing Disease Management, Diabetes Care
09/13/2023

Featuring Daniel Sontupe, Todd Prewitt, MD, and Yash Prajapati

Featuring Daniel Sontupe, Todd Prewit...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
Switching to Biosimilars Yields Significant Cost Savings For Patients Taking Insulin
04/13/2023
Maria Asimopoulos
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
Headshot of Ann Latner, JD
Commentary
Kansas Attorney General Files Insulin Lawsuit Against Manufacturers, PBMs
01/17/2023
Ann W Latner, JD
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a...
01/17/2023
Pharmacy Learning Network
Headshot of German Hernandez, fellow of the American Society of Nephrology
Commentary
Diabetes Awareness Month: Nutrition Tips for Managing Type 2 Diabetes and ADPKD
11/18/2021

German Hernandez, MD, FASN contributor

German Hernandez, MD, FASN contributo...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides...
11/18/2021
First Report Managed Care
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
Interview
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
03/17/2020
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD,...
03/17/2020
First Report Managed Care
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
Interview
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
03/10/2020
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive...
03/10/2020
First Report Managed Care
Interview
Improving Multiple Outcomes With One Treatment
07/09/2019
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president...
07/09/2019
First Report Managed Care
Interview
Social Risk Adjustment Important for Alternative Payment Model Success, Health Outcomes
04/17/2019
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior...
04/17/2019
First Report Managed Care

Interactive Features

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
FDA Approves ANDA for Donepezil
02/24/2016
The FDA has approved an Abbreviated New Drug Application for the treatment of mild, moderate, and severe Alzheimers disease. For information on 2015 sales, generic competitors, and a 2016 shipping plan.  
The FDA has approved an Abbreviated New Drug Application for the treatment of mild, moderate, and severe Alzheimers disease. For information on 2015 sales, generic competitors, and a 2016 shipping plan.  
The FDA has...
02/24/2016
First Report Managed Care
News
Medicare Could Save $1 Billion by Considering Added Benefit of Expensive Part B Drugs
07/18/2023
Jolynn Tumolo
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare...
07/18/2023
First Report Managed Care
Feature
Trends in Use of Pharmaceutical Therapies for Diabetes, 1997-2007
02/15/2011

Tori Socha

Tori Socha
The recommended treatment goal for patients with diabetes is hemoglobin (Hb) A1C <7%. For patients with type 1 diabetes, the standard treatment is insulin, whereas patients diagnosed with type 2 diabetes follow a stepwise treatment regimen...
The recommended treatment goal for patients with diabetes is hemoglobin (Hb) A1C <7%. For patients with type 1 diabetes, the standard treatment is insulin, whereas patients diagnosed with type 2 diabetes follow a stepwise treatment regimen...
The recommended treatment goal...
02/15/2011
First Report Managed Care
News
When Care Is Split Between Medicare And Medicaid: KHN Interview With Melanie Bella
02/24/2011
02/24/2011
First Report Managed Care
Stakeholders Still Searching for Solutions to Lower Costs of Gene Therapy
03/31/2020

Jeff Craven

Jeff Craven
With more therapies than ever moving through the pipeline, developers and payers are looking at new ways to lower costs while ramping up gene therapy production.
With more therapies than ever moving through the pipeline, developers and payers are looking at new ways to lower costs while ramping up gene therapy production.
With more therapies than ever...
03/31/2020
First Report Managed Care

Video Insights

Headshots
Videos
How Digital Therapeutics Are Changing Disease Management, Diabetes Care
09/13/2023

Featuring Daniel Sontupe, Todd Prewitt, MD, and Yash Prajapati

Featuring Daniel Sontupe, Todd Prewit...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement